Limited coverage drugs – ondansetron

Last updated on October 6, 2022

Special Authority requests can now be submitted online. It's simple and quick!

Generic name / strength / form
ondansetron - all strengths and forms

Criteria	Approval period
Prevention and treatment of nausea and vomiting associated with chemotherapy.	First approval: six months Renewals: six months

Criteria

Approval period

Prevention and treatment of nausea and vomiting associated with chemotherapy.

First approval: six months

Renewals: six months

Practitioner exemptions

Oncologist (medical)
Oncologist (radiation)

Special notes

None

Special Authority requests

Log in to eForms
HLTH5328 Special Authority Request (PDF, 524KB)

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics

Limited coverage drugs – ondansetron

Practitioner exemptions

Special notes

Special Authority requests